NBTX CIK: 1760854

Nanobiotix S.A.

  • France
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions EUR
FY21:
93.1
FY22:
52.4
FY23:
87.3
FY24:
61.5
FY25:
62.8
(positive)
Change from FY21 to FY25
millions EUR
FY21:
8.71
FY22:
7.41
FY23:
6.56
FY24:
5.95
FY25:
5.01
Total assets
Change from FY21 to FY25
millions EUR
FY21:
102
FY22:
59.8
FY23:
93.9
FY24:
67.4
FY25:
67.8

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions EUR
FY21:
36.8
FY22:
37.9
FY23:
49.9
FY24:
58.9
FY25:
57.5
(negative)
Change from FY21 to FY25
millions EUR
FY21:
38.1
FY22:
–
FY23:
45.9
FY24:
74.2
FY25:
94.7
(positive)
Change from FY21 to FY25
millions EUR
FY21:
26.8
FY22:
−27.0
FY23:
−1.84
FY24:
−65.7
FY25:
−84.5
Total liabilities & equity
Change from FY21 to FY25
millions EUR
FY21:
102
FY22:
–
FY23:
93.9
FY24:
67.4
FY25:
67.8

All amounts in millions EUR Data sources:SEC EDGARTwelve Data